- {{x.value}}
{{ twilioFailed ? 'SMS Code Failed to Send…' : 'Enter your SMS code' }}
A text message with your verification code was just sent to {{user.DayPhone}}
We cannot send you a code via SMS to {{user.DayPhone}}
Hi {{ user.FirstName }}, please provide your mobile number.
{{ content.trialHeading.replace('{0}', user.FirstName) }}
We'll send you a text message with a verification code to start your free {{ '2' == '1' ? 'Eureka Report' : 'Intelligent Investor' }} 15-day trial.
{{ content.upgradeHeading.replace('{0}', user.FirstName) }}
The email address you entered is registered with InvestSMART.
Please login to continue
We have sent you an email with the details of your registration.
Looks you are already a member. Please enter your password to proceed
{{ upgradeCTAText }}
Updating information
Please wait ...
Your membership to InvestSMART Group recently failed to renew.
Please make sure your payment details are up to date to continue your membership.
Having trouble renewing?
Please contact Member Services on support@investsmart.com.au or 1300 880 160
You've recently updated your payment details.
It may take a few minutes to update your subscription details, during this time you will not be able to view locked content.
If you are still having trouble viewing content after 10 minutes, try logging out of your account and logging back in.
Still having trouble viewing content?
Please contact Member Services on support@investsmart.com.au or 1300 880 160
Please click on the ACTIVATE button to activate your Eureka Report 15-day free trial
Please click on the ACTIVATE button to activate your Intelligent Investor 15-day free trial
Please click on the ACTIVATE button to finalise your membership
Unsuccessful registration
Registration for this event is available only to Eureka Report members. View our membership page for more information.
Registration for this event is available only to Intelligent Investor members. View our membership page for more information.
- You are already registered for this event.
- This event is already full.
- Please select a quantity for at least one ticket.
- {{ i }}
Forgotten password
Please enter your email address below to request a new password
- Indepth analysis of ASX listed shares
- BUY, Hold and Sell Recommendations
- Ideas Lab
- Special Reports
- Alan Kohler’s Weekend Briefing
- Interviews with CEO’s & top influencers
- Money Cafe and Talking Finance
- Super Advice and Q&A with Ask Alan
SomnoMed Limited (SOM) - Research
SOM General Information +
| ASX Code | SOM |
| Website | http://www.somnomed.com.au |
| GICS Sub-Industry | Health Care Equipment |
| Market Cap ($M) | 135 |
| Current Price | $2.150 |
| Day High | $2.150 |
| Day Low | $2.150 |
| Last Close | $2.150 |
| Price Movement | - ( No change ) |
SOM Company Overview
Business Description
SOM Financial Summary
| Year to Jun | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2019 A | 0.10 | 0.20 | 0.00% | 1,133.30 | 0.00 | 0.00% | 0.0% |
| 2018 A | -10.57 | -15.30 | 0.00% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2017 A | -4.09 | -6.10 | 0.00% | 0.00 | 0.00 | 0.00% | 0.0% |
SOM Peer Comparison
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2017 A | 2018 A | 2019 A | 2017 A | 2018 A | 2019 A | 2017 A | 2018 A | 2019 A | ||
| Cochlear (COH) | $12,076M | 0.0937 | 0.1190 | 0.0903 | 45.3362 | 40.5143 | 37.1602 | 1.58% | 1.72% | 1.88% |
| Fisher & Paykel Hlth (FPH) | $9,023M | 0.1494 | 0.0576 | 0.1263 | 40.7782 | 38.5578 | 34.2334 | 1.42% | 1.68% | 1.90% |
| ResMed (RMD) | $8,213M | 0.0460 | 0.0309 | 0.1236 | 42.6362 | 41.3567 | 36.8065 | 1.09% | 1.12% | 1.21% |
| SomnoMed (SOM) | $135M | 0.0000 | 0.0000 | 0.0000 | 1,343.7500 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
SOM Market Comparison
| Earnings | P/E Ratio | P/B Ratio | P/E Growth | |
|---|---|---|---|---|
| Company | 1.71 | 1,343.00 | 6.96 | 0.00 |
| Market | 0.64 | 17.80 | 1.26 | 1.32 |
| Sector | 0.95 | 19.60 | 1.93 | 5.67 |
SOM Directors
| Name | Position | Start Date |
|---|---|---|
| Ms Lee Ausburn | Non-Executive Director | 30 Sep 2011 |
| Mr Robert Scherini | Non-Executive Director | 30 Sep 2011 |
| Mr Hamish Corlett | Non-Executive Director | 1 May 2018 |
| Dr Peter Neustadt | Non-Executive Director, Non-Executive Chairman | 13 Nov 2006 |
SOM Management
| Name | Position |
|---|---|
| Derek Smith | Chief Executive Officer |
| Jim Evanger | Chief Executive Officer of Renew Sleep Solutions, Inc. |
| Neil Verdal-Austin | Chief Financial Officer and Executive Vice President Asia Pacific |
| Terence Anthony Flitcroft | Company Secretary |
| Kien Nguyen | Executive President - North America |
| Martin Weiland | Executive Vice President - Sales and Marketing Europe |
SOM Substantial Shareholders
| Holding | Name |
|---|---|
| 12,422,014 (19.97%) | TDM Asset Management Pty Ltd and its associates |
| 5,122,846 (8.23%) | Dottie Investments Pty Limited |
| 3,424,861 (5.51%) | National Nominees Ltd |
| 3,377,651 (5.43%) | FIL Limited and the entities |
SOM Calendar of Events
| Date | Event |
|---|---|
| 19 August 2020 | Report (Prelim) |
| 20 February 2020 | Report (Interim) |
| 27 September 2019 | Report (Annual) |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.
